Constantinos Giaginis Selected Research

Cyclooxygenase 2 (Cyclooxygenase-2)

7/2018	Elevated Hu-Antigen Receptor (HuR) Expression is Associated with Tumor Aggressiveness and Poor Prognosis but not with COX-2 Expression in Invasive Breast Carcinoma Patients.
1/2016	Clinical Significance of Hu-Antigen Receptor (HuR) and Cyclooxygenase-2 (COX-2) Expression in Human Malignant and Benign Thyroid Lesions.
1/2015	Hu-antigen receptor (HuR) and cyclooxygenase-2 (COX-2) expression in human non-small-cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Constantinos Giaginis Research Topics

Disease

61	Neoplasms (Cancer) 11/2023 - 06/2006
11	Obesity 03/2024 - 06/2018
11	Adenocarcinoma 09/2017 - 06/2008
10	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2009
10	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2017 - 02/2011
7	Overweight 03/2024 - 01/2023
7	Disease Progression 03/2024 - 06/2011
7	Inflammation (Inflammations) 01/2024 - 09/2014
6	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2012
5	Carcinogenesis 10/2021 - 10/2015
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2017 - 02/2014
4	Lymphatic Metastasis 01/2017 - 03/2010
4	Pancreatic Neoplasms (Pancreatic Cancer) 02/2013 - 05/2009
3	Premature Birth (Birth, Premature) 04/2024 - 07/2023
3	Gestational Diabetes (Gestational Diabetes Mellitus) 04/2024 - 01/2023
3	Multiple Sclerosis 03/2024 - 11/2023
3	COVID-19 02/2024 - 01/2023
3	Infections 02/2024 - 03/2010
3	Pediatric Obesity 12/2023 - 03/2023
3	Insulin Resistance 12/2023 - 02/2023
3	Chronic Disease (Chronic Diseases) 11/2023 - 06/2018
3	Sarcopenia 08/2023 - 02/2023
3	Hypertension (High Blood Pressure) 01/2023 - 07/2010
3	Carcinoma (Carcinomatosis) 10/2021 - 01/2016
3	Colorectal Neoplasms (Colorectal Cancer) 09/2017 - 10/2009
3	Atherosclerosis 05/2017 - 07/2011
3	Colonic Neoplasms (Colon Cancer) 01/2015 - 02/2009
3	Carotid Artery Diseases 10/2012 - 07/2010
2	Mental Disorders (Mental Disorder) 04/2024 - 05/2023
2	Abdominal Obesity 03/2024 - 12/2023
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2024 - 11/2023
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 06/2018
2	Cognitive Dysfunction 11/2023 - 04/2021
2	Gestational Weight Gain 10/2023 - 02/2018
2	Asthma (Bronchial Asthma) 03/2023 - 01/2023
2	Pain (Aches) 02/2023 - 02/2011
2	Stroke (Strokes) 12/2022 - 07/2011
2	Tongue Neoplasms (Tongue Neoplasm) 08/2012 - 02/2011

Drug/Important Bio-Agent (IBA)

34	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2009
16	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2009
9	AntigensIBA 07/2018 - 06/2008
8	Histone Deacetylase InhibitorsIBA 01/2021 - 10/2011
7	LigandsIBA 02/2022 - 05/2009
6	Eph Family Receptors (Eph Receptors)IBA 02/2022 - 06/2010
6	ParaffinIBA 10/2021 - 06/2008
5	EnzymesIBA 01/2024 - 10/2009
5	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 02/2013
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2012
4	EphrinsIBA 02/2022 - 06/2010
4	Transcription Factors (Transcription Factor)IBA 09/2014 - 05/2009
3	CurcuminIBA 04/2024 - 06/2018
3	Histones (Histone)IBA 05/2023 - 10/2011
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2018 - 01/2015
3	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2017 - 08/2010
3	Messenger RNA (mRNA)IBA 01/2016 - 01/2015
3	Retinoid X Receptors (Retinoid X Receptor)IBA 10/2015 - 05/2009
2	AlbuminsIBA 03/2024 - 10/2023
2	Protective AgentsIBA 02/2024 - 11/2023
2	ResveratrolIBA 02/2024 - 01/2024
2	MicronutrientsIBA 02/2024 - 12/2023
2	Indicators and Reagents (Reagents)IBA 01/2024 - 02/2009
2	Vitamin D FDA LinkGeneric 11/2023 - 02/2023
2	AntioxidantsIBA 10/2023 - 01/2023
2	CarbohydratesIBA 02/2023 - 11/2017
2	Lipoproteins (Lipoprotein)IBA 02/2023 - 05/2017
2	Phenobarbital (Luminal)FDA Link 10/2021 - 07/2018
2	Pregnane X ReceptorIBA 10/2021 - 10/2015
2	RNA (Ribonucleic Acid)IBA 11/2018 - 01/2015
2	Antigen Receptors (Antigen Receptor)IBA 07/2018 - 01/2015
2	PaxillinIBA 09/2017 - 01/2017
2	Bile Acids and Salts (Bile Acids)IBA 05/2017 - 01/2012
2	CannabinoidsIBA 03/2016 - 01/2016
2	Antineoplastic Agents (Antineoplastics)IBA 01/2015 - 01/2014
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2012 - 02/2011
2	HomocysteineIBA 10/2012 - 07/2010
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2012 - 08/2010
2	Retinoid X Receptor alphaIBA 07/2011 - 05/2009
2	PPAR gammaIBA 07/2011 - 05/2009
1	Ferritins (Ferritin)IBA 03/2024
1	SeleniumIBA 02/2024
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 02/2024
1	Glutamine (L-Glutamine)FDA Link 02/2024
1	VitaminsIBA 02/2024
1	beta-GlucansIBA 02/2024
1	MagnesiumIBA 02/2024
1	ZincIBA 02/2024
1	IronIBA 02/2024
1	C-Reactive ProteinIBA 01/2024
1	QuercetinIBA 01/2024
1	ThymolIBA 01/2024
1	Amylases FDA Link 01/2024
1	BerberineIBA 01/2024
1	Lipase (Acid Lipase)FDA Link 01/2024

Therapy/Procedure

15	Mediterranean Diet 04/2024 - 02/2018
13	Therapeutics 05/2023 - 07/2010
6	Cesarean Section (Caesarean Section) 04/2024 - 01/2023
5	Drug Therapy (Chemotherapy) 01/2023 - 03/2013
3	Radiotherapy 01/2023 - 01/2016
2	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 12/2023 - 02/2023
2	Chemoprevention 08/2012 - 02/2011